Many people suffer from serious medical conditions that might be alleviated by CBD, so it is “critical” that such an evaluation be completed to determine whether there is a scientific basis to make CBD a legal controlled substance while keeping marijuana illegal under federal law, wrote Grassley and Feinstein, chair and co-chair, respectively, of the Senate’s Caucus on International Narcotics Control (http://1.usa.gov/1WwMvH8; http://1.usa.gov/1sLHOg2).
Last year, Nora Volkow, MD, director of the National Institute on Drug Abuse, told the caucus that “[i]n addition to epilepsy, the therapeutic potential of CBD is currently being explored for a number of indications, including anxiety disorders, substance use disorders, schizophrenia, cancer, pain, inflammatory diseases, and others.” (http://1.usa.gov/1VPfD8Q)
